The Farapulse Farawave catheter and Faraview software. [Image courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + announced today that it received FDA approval for its navigation ...

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) has announced the FDA approval of its FARAWAVE™ NAV Ablation Catheter and the 510(k) clearance of FARAVIEW™ Software, designed to ...

Boston Scientific is launching the Farawave Nav ablation catheter and Faraview software to treat atrial fibrillation in the U.S. · MedTech Dive · Courtesy of Boston Scientific Boston Scientific ...

Boston Scientific collected a set of FDA green lights ... allowing it to combine cardiac mapping sensors and therapy delivery in a single catheter. The Farawave Nav probe adds magnetic navigation ...

Boston Scientific Corporation BSX has secured FDA approval for its FARAWAVE NAV Ablation Catheter and 510(k) clearance for FARAVIEW Software, offering integrated mapping and pulsed-field ablation ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) has announced the FDA approval of its FARAWAVE™ NAV Ablation Catheter and the 510(k) clearance of FARAVIEW™ Software, designed to enhance ...

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.